FDA Orange Book

Generic for D.h.e.

D.h.e. contains dihydroergotamine. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

Yes. The generic name for D.h.e. is dihydroergotamine. 5 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AP.

Run it in Rivvi

Map D.h.e. and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

D.h.e. products in the Orange Book

D.h.e. products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
injectable, injection1MG/MLDiscontinuedNone5AP

NDA 005929, held by BAUSCH HEALTH US LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Approved generic dihydroergotamine

Approved generic versions of D.h.e.
CompanyANDATE codeApprovedStrengths
HIKMA PHARMACEUTICALS USA INC040453AP (A-rated, therapeutically equivalent)June 9, 20031MG/ML
HIKMA PHARMACEUTICALS206621AP (A-rated, therapeutically equivalent)September 15, 20171MG/ML
SAGENT PHARMACEUTICALS INC207264AP (A-rated, therapeutically equivalent)July 11, 20181MG/ML
MILLA PHARMACEUTICALS INC212046AP (A-rated, therapeutically equivalent)January 7, 20201MG/ML
GLAND PHARMA LTD215623AP (A-rated, therapeutically equivalent)August 18, 20231MG/ML

Questions

Is there a generic for D.h.e.?

Yes. The generic name for D.h.e. is dihydroergotamine. 5 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AP.

What is the generic name for D.h.e.?

The active ingredient in D.h.e. is dihydroergotamine, per the FDA Orange Book.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on D.h.e. and Dihydroergotamine

Try it on your own data today.

Free to start. Most teams are using it the same day.